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The antiretroviral factor tripartite motif protein 5 (TRIM5) gene-derived isoform (TRIMCyp) has
been found in at least three species of Old World monkey: rhesus (Macaca mulatta), pig-tailed
(Macaca nemestrina) and cynomolgus (Macaca fascicularis) macaques. Although the frequency
of TRIMCyp has been well studied in rhesus and pig-tailed macaques, the frequency and
prevalence of TRIMCyp in cynomolgus macaques remain to be definitively elucidated. Here, the
geographical and genetic diversity of TRIM5a/TRIMCyp in cynomolgus macaques was studied in
comparison with their anti-lentiviral activity. It was found that the frequency of TRIMCyp in a
population in the Philippines was significantly higher than those in Indonesian and Malaysian
populations. Major and minor haplotypes of cynomolgus macaque TRIMCyp with single
nucleotide polymorphisms in the cyclophilin A domain were also found. The functional significance
of the polymorphism in TRIMCyp was examined, and it was demonstrated that the major haplotype
of TRIMCyp suppressed human immunodeficiency virus type 1 (HIV-1) but not HIV-2, whilst the
minor haplotype of TRIMCyp suppressed HIV-2 but not HIV-1. The major haplotype of TRIMCyp
did not restrict a monkey-tropic HIV-1 clone, NL-DT5R, which contains a capsid with the simian
immunodeficiency virus-derived loop between a-helices 4 and 5 and the entire vif gene. These
results indicate that polymorphisms of TRIMCyp affect its anti-lentiviral activity. Overall, the results
of this study will help our understanding of the genetic background of cynomolgus macaque
TRIMCyp, as well as the host factors composing species barriers of primate lentiviruses.
INTRODUCTION
Human immunodeficiency virus type 1 (HIV-1) barely
replicates in Old World monkeys such as cynomolgus
macaques (CMs; Macaca fascicularis) and rhesus macaques
(RMs; Macaca mulatta). This species barrier has long
hampered the use of Old World monkeys for human
immunodeficiency virus type 1 (HIV-1) research. Recently, a
number of intrinsic anti-HIV-1 cellular factors, including
tripartite motif protein 5a (TRIM5a), cyclophilin A
(CypA), the apolipoprotein B mRNA-editing enzyme
catalytic polypeptide-like 3 (APOBEC3) family and tetherin
wereidentifiedinOldWorldmonkeycells(Nomaguchietal.,
2008; Sauter et al., 2010). Of these factors, TRIM5a was
found to strongly suppress HIV-1 replication, mainly by
affecting the virus disassembly step, resulting in a decrease in
reverse-transcription products (Nakayama & Shioda, 2010;
Stremlau et al., 2004). TRIM5a contains a RING domain, a
B-box domain, a coiled-coildomainand a PRYSPRY(B30.2)
domain. Importantly, the PRYSPRY domain recognizes the
capsid of incoming retroviruses, leading to post-entry
restriction of infection. RM and CM TRIM5a restrict HIV-
1 but not simian immunodeficiency virus isolated from an
infected rhesus macaque (SIVmac) (Nakayama et al., 2005;
Stremlau et al., 2004; Yap et al., 2004). In the case of HIV-2
3These authors contributed equally to this work.
The GenBank/EMBL/DDBJ accession numbers for the sequences of
CM TRIMCyp-major (DK) and RM TRIMCyp are AB671588 and
AB671589, respectively.
Two supplementary tables are available with the online version of this
paper.
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protein are sensitive to CM TRIM5a, whereas those with
either alanine or glutamine (Q) are resistant (Song et al.,
2007). Both CM TRIM5a-sensitive and -resistant HIV-2
strains are restricted by RM TRIM5a, and three amino acid
residues – threonine (T), phenylalanine (F) and P at aa 339,
340 and 341, respectively – of RM TRIM5a are important for
restrictingparticularHIV-2strains,whicharestillresistantto
CM TRIM5a (Kono et al., 2008). It is also known that
TRIM5a exhibits a high degree of sequence variation, even
within macaque species. In some individual RMs, the TFP
residues at aa 339–341 of TRIM5a are replaced with a single
Q (Newman et al., 2006) and this TFPAQ polymorphism
affects the anti-lentiviral activity of RM TRIM5a (Kirmaier
et al., 2010).
Although pig-tailed macaques (PMs; Macaca nemestrina)
have long been thought to exhibit a higher susceptibility to
HIV-1 infection than RMs and CMs (Agy et al.,1 9 9 2 ) ,t h e
underlying mechanism determining this difference remained
unclear. Recently, a TRIM5–CypA chimeric protein, referred
to as TRIMCyp, was discovered in PMs, and the monkeys
exclusively expressed TRIMCyp but not TRIM5a (Brennan
et al., 2008; Liao et al., 2007). TRIMCyp is an alternatively
spliced isoform of the TRIM5 gene in which the PRYSPRY
domain of TRIM5a is replaced with a retrotransposed CypA
gene. The retrotransposition of the CypA sequence in the 39
UTR of the TRIM5 gene correlates with a single nucleotide
polymorphism (SNP) at the exon 7 splice-acceptor site,
leading to skipping of exons 7 and 8 encoding the PRYSPRY
domain and splicing to the CypA insertion. Thus, the
presence or absence of the CypA sequence in the 39 UTR
results in expression of TRIMCyp or TRIM5a, respectively.
In vitro analyses demonstrated that cells expressing PM
TRIMCyp restricted HIV-2 but not HIV-1 infection
(Brennan et al., 2008; Liao et al., 2007), suggesting that the
characteristic isoform of the TRIM5 gene in PMs may be one
of the reasons for their greater susceptibility to HIV-1
infection. Furthermore, TRIMCyp was also identified in some
individualRMsandCMs(Brennanetal.,2008;Newmanetal.,
2008; Wilson et al., 2008a). RM TRIMCyp, as well as that of
PMs, is unable to restrict HIV-1 infection (Wilson et al.,
2008a). This report also showed that the frequency of
T R I M C y pi nI n d i a nR M sw a sa p p r o x i m a t e l y2 5% ,w h i l s ti t
was not found in the Chinese RM population, suggesting a
geographical deviation in the frequency of TRIMCyp (Wilson
et al., 2008a). In the case of CMs, although the existence of
TRIMCyp has been reported (Brennan et al., 2008), the allele
frequency,geographical distribution and relevance in antiviral
activity of TRIMCyp remain to be elucidated. As the TRIM5
gene-related factors are expected to have an impact on the
replication of retroviruses, information about the genetic
background of CM TRIMCyp will contribute to our
understanding of host factors composing the species barrier.
In the present study, we studied the geographical, genetic and
functional diversity of CM TRIMCyp originating from
South-West Asia (Indonesia, Malaysia and the Philippines).
We showed a geographical deviation in the frequency of
TRIMCyp. Moreover, we found SNPs in CM TRIMCyp
and analysed their impact on the anti-lentiviral functions,
including their effect against HIV-1, HIV-2, SIVmac and
monkey-tropic HIV-1 (HIV-1mt).
RESULTS
Geographical deviation in the frequency of CM
TRIMCyp
Initially, we analysed the frequencies of TRIM5a and
TRIMCyp genotypes in 126 CMs originating from three
different regions – Indonesia, Malaysia and the Philippines –
using a PCR-based assay designed to differentiate between
the presence and absence of the CypA insertion (Fig. 1a)
(Wilson et al., 2008a). Insertion of the CypA gene in
TRIMCyp resulted in a PCR product larger than the
expected size for TRIM5a (Fig. 1b).
As shown in Table 1, 35 of the 46 Philippine individuals
were homozygous for TRIMCyp, ten were heterozygous
and only one was homozygous for TRIM5a. In contrast,
only three of the 33 Indonesian individuals were homo-
zygous for TRIMCyp, 17 were heterozygous and 13 were
homozygous for TRIM5a. Interestingly, the Malaysian
population was of intermediate proportions: ten TRIMCyp
homozygotes, 26 heterozygotes and 11 TRIM5a homo-
zygotes. As shown in Fig. 2, the percentages of individuals
having each TRIM5 genotype indicated that the frequency
of TRIMCyp homozygotes in Malaysian CMs was twice
that in Indonesian CMs. In contrast, the frequency of
TRIM5a homozygotes in Indonesian CMs was twice that
in Malaysian CMs. Taken together, the calculated allele
frequencies of TRIMCyp in the Philippine, Indonesian and
Malaysian CM populations were 87.0, 34.8 and 48.9%,
respectively (Table 1). Statistical analyses using a x
2 test
followed by Bonferroni correction demonstrated that the
frequency of TRIMCyp in the Philippine population was
significantly higher than that in the Indonesian (P,0.0001)
and Malaysian (P,0.0001) populations. In contrast, there
was no significant difference between the Indonesian and
Malaysian populations (P50.2295).
It should be noted that our method failed to distinguish
homozygotes from hemizygotes, especially when the sub-
jects exhibited no polymorphisms in the TRIM5 gene.
However, hemizygosity for the TRIM5 gene is highly
unlikely for the following reasons: (i) the TRIM5 gene is on
an autosomal chromosome, (ii) there is no precedent of
deletion of the TRIM5 gene in humans or primates, and
(iii) all of the three CM populations in Table 1 are in
Hardy–Weinberg equilibrium for TRIM5 genotypes.
Polymorphisms in the CypA domain of CM
TRIMCyp
Previously, it was reported that aa 357 of CM TRIMCyp,
corresponding to aa 54 counting from the methionine of
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http://vir.sgmjournals.org 595CypA, wasarginine (R)(Brennan et al.,2008).Subsequently,
Ylinen et al. (2010) reported another allele of CM TRIMCyp
encoding histidine (H) at this position. To determine the
frequency of this RAH polymorphism, we examined 34
TRIM5a/TRIMCyp heterozygotes and 30 TRIMCyp homo-
zygotes for sequence variations in the CypA domain. The
results showed that there was no TRIMCyp allele encoding
R at position 357 (Cyp 54R). All 94 CM chromosomes
carrying the TRIMCyp gene encoded TRIMCyp with H at
this position. This result was consistent with the results
reported recently by Dietrich et al. (2011).
Dietrich et al. (2011) also reported CM TRIMCyp poly-
morphisms at aa 369 and 446, corresponding to aa 66 and
143 in the CypA domain, respectively. Both Brennan et al.
(2008) and Ylinen et al. (2010) reported that aa 369 (Cyp66)
and 446 (Cyp143) are aspartic acid (D) and lysine (K),
respectively (denoted as the DK haplotype), whilst Dietrich
et al. (2011) showed the presence of another haplotype
encoding asparagine (N) and glutamic acid (E) at positions
369 (Cyp66) and 446 (Cyp143), respectively (denoted as the
NE haplotype). Our results showed that 12 CM chromo-
somes carried TRIMCyp with the NE haplotype, whilst the
remaining 82 TRIMCyp were all the DK haplotype (Table 2).
Residues 369N (Cyp 66N) and 446E (Cyp 143E) were also
found in PM and RM TRIMCyps, and the CypA portion
of the NE haplotype of CM TRIMCyp has the same amino
acid sequence as RM TRIMCyp (GenBank accession
no. EU157763). These results indicate that the previously
recognized interspecies variations of the CypA sequence of
TRIMCyp were in fact intraspecies variation within CMs.
With respect to the geographical distribution of these haplo-
types, we found no significant deviation in the frequencies of
the haplotypes among the three origins (Table 2).
Polymorphisms in the RING, B-box, coiled-coil,
linker and PRYSPRY domains of CM TRIM5a and
TRIMCyp
To identify polymorphisms that are in possible linkage
disequilibrium with either the DK or NE haplotype in
regions other than the CypA domain, we determined
nucleotide sequences of TRIM5a and TRIMCyp cDNAs
encoding the RING, B-box, coiled-coil and linker domains
of six TRIMCyp homozygotes (three homozygotes of the
DK haplotype and three heterozygotes for the DK and
NE haplotypes) and three TRIM5a homozygotes (see
Supplementary Table S1, available in JGV Online). We
found polymorphisms at positions 4 [EAglycine (G)] in
1
TRIM5a
TRIMCyp
(a)
(b)
TRIM5a
TRIMCyp
234 5 6 7 8 Reverse
Reverse CypA
Forward
Forward
1
M12 2 3 4 5 6 7 8 9 10 11 12 13 DW
234 5 6 7 8 Fig. 1. Determination of CypA insertion. (a)
Diagram indicating the splicing of TRIM5a or
TRIMCyp. Non-coding and coding exons
(numbered) and CypA sequences are indi-
cated as open, shaded and filled boxes,
respectively. The primers used in this study
are indicated by arrows. (b) Genomic DNA
was extracted from PBMCs. To test for CypA
insertion, the 39 region of the TRIM5 gene was
amplified by PCR with primers spanning the
39 UTR and the putative CypA insertion. DW,
Distilled water control.
Table 1. Frequencies of TRIMCyp alleles in CM populations
Origin No. of animals Genotype (no. of animals) Allele frequency (%)
TRIM5a
homozygote
TRIM5a/TRIMCyp
heterozygote
TRIMCyp
homozygote
TRIM5a TRIMCyp
Philippines 46 1 10 35 13.0 87.0
Malaysia 47 11 26 10 51.1 48.9
Indonesia 33 13 17 3 65.2 34.8
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596 Journal of General Virology 93the N-terminal region, 44 (KAE) in the RING domain,
178 [HAtyrosine (Y)] and 209 (KAE) in the coiled-coil
domain, and 247 (EAD) and 285 (GAR) in the linker
domain (Fig. 3a). We found only one chromosome for
minor allele 4G, two for 44E, four for 178Y, nine for 209E,
five for 247D and four for 285R among 18 chromosomes
from the six TRIMCyp homozygotes and three TRIM5a
homozygotes. Among the six TRIMCyp homozygotes, we
also found three EAQ substitutions at aa 296, which was
present in TRIMCyp but absent from TRIM5a. There was
no polymorphism that showed strong linkage disequilib-
rium with either the DK or NE haplotype except for
G285R. The NE haplotype tended to link with 285G,
although several DK haplotypes also linked with 285G
(Supplementary Table S1). The numbers of polymorphic
positions were relatively small among CMs compared with
RMs (Fig. 3b). It is known that the coiled-coil region of
TRIM5 genes shows a high degree of genetic diversity in
RMs (Johnson & Sawyer, 2009). In contrast, the coiled-coil
domain of CM TRIM5a and TRIMCyp showed no poly-
morphism at aa 184, 196, 208, 222, 230 and 236, which
were all highly polymorphic in RMs (Newman et al., 2006).
These results suggest that the evolutionary pressures
targeting the coiled-coil domain of the TRIM5 gene were
weaker in CMs than in RMs.
We also determined the nucleotide sequences of exon 8
encoding the PRYSPRY domain, of 12 TRIM5a homo-
zygotes including the three TRIM5a homozygotes analysed
above (see Supplementary Table S2, available in JGV
Online). We found polymorphisms at aa 311 [serine (S)A
leucine (L)], 327 (PAT), 330 [valine (V)Amethionine (M)],
350 [VAisoleucine (I)] and 435 (IAV) in the PRYSPRY
domain (Fig. 3a). Among the 12 TRIM5a homozygotes, we
did not find a TFP allele at aa 339–341, which is a major
determinant for different virus specificity between CM and
RM TRIM5as (Kono et al., 2008) and is also critical for SIV
from sooty mangabeys (SIVsm) (Kirmaier et al., 2010) and
SIVmac (Lim et al., 2010) restriction by RM TRIM5a.W e
found only one chromosome for minor allele 311L, one for
327T, one for 350I and four for 435V among 11 TRIM5a
homozygotes. We previously cloned CM TRIM5a cDNA
from HSC-F cells (GenBank accession no. AB210052)
(Nakayama et al., 2005) and found that it contained 330V;
however, all of the sequences determined in the present
study showed M at this position. In contrast, exon 8 of
the TRIMCyp gene of seven TRIMCyp homozygotes (all
were heterozygotes for the DK and NE haplotypes), which
encoded the PRYSPRY domain but was absent from the
mRNA due to splicing, showed a uniform sequence identical
to that of the Mamu 7 haplotype of RMs (307P, 313V, 327P,
332R, 333T, 334Q, 339Q, 345I, 383P, 414V, 420S and
488M). We only found one FAL substitution at position
454 among the seven TRIMCyp homozygotes. The Mamu 7
sequence is thus likely to be an ancient prototype sequence
of TRIMCyp before the separation of CMs from RMs.
Anti-lentiviral activity of CM TRIMCyps
To elucidate the impact of CM TRIMCyp and its SNPs on
the anti-lentiviral activity, we constructed a recombinant
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Fig. 2. Frequency of individuals having each TRIM5 genotype.
The percentages of TRIM5a homozygotes and heterozygotes and
TRIMCyp homozygotes in each population were calculated. Grey
bars, TRIM5a homozygote; white bars, heterozygote; black bars,
TRIMCyp homozygote.
Table 2. Frequencies of DK and NE haplotypes in CM TRIMCyps
Origin No. of animals Genotype (no. of chromosomes) Frequency (%)
TRIM5a/TRIMCyp
heterozygote*
TRIMCyp homozygoteD DK NE
DK NE DK NE
Philippines 28 6 1 36 6 85.7 14.3
Malaysia 21 14 1 10 2 88.9 11.1
Indonesia 15 12 0 4 2 88.9 11.1
*Haplotypes were determined by direct sequencing of the PCR products.
DHaplotypes were inferred by maximum-likelihood estimation using the results of direct sequencing of the PCR products.
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http://vir.sgmjournals.org 597Sendai virus (SeV) expressing a series of TRIM5a/
TRIMCyp: CM TRIM5a, the DK and NE haplotypes of
the CM TRIMCyp [CM TRIMCyp-major (DK) and CM
TRIMCyp-minor (NE)], CM SPRY (2) in which the
PRYSPRY domain was deleted as a negative control for
functional TRIM5a and TRIMCyp, and an RM TRIMCyp.
We also constructed a recombinant SeV expressing a CM
TRIMCyp-minor (NE) carrying G at position 285 (CM
TRIMCyp-minor R285G), as the NE haplotype seemed
to be in linkage disequilibrium with G at this position
(Supplementary Table S1). As shown in Fig. 4[(a), upper
panels], TRIMCyp-major (DK) completely restricted HIV-
1 NL4-3, weakly restricted HIV-2 GH123 and failed to
restrict SIVmac239. In contrast, TRIMCyp-minor (NE)
and TRIMCyp-minor R285G inefficiently restricted HIV-
1 NL4-3, barely restricted SIVmac239 and completely
restricted HIV-2 GH123. These results indicated that the
sequence variations in CM TRIMCyp greatly altered the
spectrum of its anti-lentiviral activity. It should be noted
that HIV-1 NL4-3 attained slightly higher titres at day 3 in
cells expressing TRIMCyp-minor R285G than in those
expressing TRIMCyp-minor (NE). The difference was small
but reproducible in six independent experiments. This result
indicated that aa 285 of TRIMCyp also affected its antiviral
activity. In the case of RMs, in which the CypA domain of
TRIMCyp has the same amino acid sequence as CM
TRIMCyp-minor (NE), RM TRIMCyp showed the same
spectrum of anti-lentiviral activity as CM TRIMCyp-minor
(NE) (Fig. 4a, lower panels), consistent with previous
reports (Price et al., 2009; Wilson et al., 2008a).
Finally, we examined whether HIV-1mt NL-DT5R (Kamada
et al., 2006) could evade restriction by CM TRIM5a/
TRIMCyp. HIV-1mt possesses core antigen (CA) with the
SIVmac239-derived loop between a-helices 4 and 5 (L4/5),
which corresponds to a CypA-binding loop of HIV-1, the
entire SIVmac239 vif gene and two non-synonymous
substitutions in the env gene (Fig. 4b). As shown in Fig.
4(c), NL-DT5R was restricted by TRIM5a but completely
evaded restriction byCM TRIMCyp-major (DK), suggesting
that replacement of the CypA-binding loop of HIV-1 CA
with the corresponding SIVmac239-derived sequence was
sufficient to render HIV-1 resistant to the major haplotype
of CM TRIMCyp but not TRIM5a.
DISCUSSION
In the present study, we analysed the geographical, genetic
and functional diversity of CM TRIMCyp and found: (i) a
clear geographical deviation in the frequency of TRIMCyp,
(ii) no typical geographical deviation in the frequency of
the DK/NE haplotypes in the CypA domain, and (iii)
sequence variations in the CypA domain of CM TRIMCyp,
which greatly altered the spectrum of its anti-lentiviral
activity.
We first demonstrated that the allele frequency of TRIMCyp
in CMs from the Philippines was significantly higher than
those in Indonesian and Malaysian CMs. It is possible that
some pathogen(s) resistant to the antiviral effect of either
TRIM5a or TRIMCyp may contribute to this deviation as a
selective pressure. As primate lentiviruses such as HIV-1 and
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Fig. 3. Sequence variations in TRIM5a and TRIMCyp. (a)
Sequence variations in CM TRIM5a and TRIMCyp. The RING, B-
box, coiled-coil, PRYSPRY and CypA domains of CM TRIM5a and
TRIMCyp are indicated by open boxes. The box with thin lines
shows exons 7 and 8 of the TRIMCyp gene, which is absent from
the mRNA. Polymorphisms are shown outside the boxes, with
downward and upward arrows indicating the polymorphisms
observed among TRIM5a homozygotes and TRIMCyp homozy-
gotes, respectively. Amino acid residues found in HSC-F cells are
shown in front of the amino acid positions, followed by the
observed polymorphisms. Major alleles are shown in bold.
Numbers in parentheses indicate amino acid positions counting
from the initiation methionine codon of the CypA ORF. Amino acid
residues in the boxes are polymorphic in the RM TRIM5 gene but
lack polymorphism in CM TRIM5a or TRIMCyp. Positions of these
amino acid residues are shown below the boxes. (b) Sequence
variations of RM TRIM5a (Mamu 1–6) and TRIMCyp (Mamu 7).
Downward and upward arrows indicate the polymorphisms
observed in TRIM5a and TRIMCyp, respectively. Amino acid
residues in boxes indicate those of RM TRIMCyp. Positions of
these amino acid residues are shown below the boxes.
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598 Journal of General Virology 93SIV originated in African primates, it is unlikely that these
viruses could contribute directly to this deviation, and some
exogenous and endogenous retroviruses may thus play a
critical role in this selection. Alternatively, it is possible that
this deviation could come from bottleneck effects. It is
estimated that the Philippine CMs were derived from
Indonesian CM stocks via sea rafting or terrestrial access
through Borneo during periods of low sea level in South-
East Asia around 110000 years ago (Abegg & Thierry, 2002;
Blancher et al., 2008; Kita et al., 2009). Furthermore,
phylogenetic analyses of mitochondrial DNA sequences
of four CM populations distributed in South-East Asia
suggested that Philippine CMs were derived from the small
founding populations of Indonesian CMs, resulting in low
genetic and nucleotide diversities (Blancher et al., 2008).
Importantly, however, as the Philippine CMs involved in
this study at least originated from Luzon and Mindanao, the
results in this study may reflect the frequency of TRIMCyp
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supernatants were assayed separately for levels of p24, p25 or p27. (b) Structure of HIV-1mt NL-DT5R used in the experiment
shown in Fig. 3(c). Open boxes denote HIV-1 (NL4-3) and shaded boxes denote SIVmac239 sequences. (c) MT4 cells were
infected with recombinant SeV expressing CM TRIM5a (CM T5a; X), CM TRIMCyp-major (DK) (CM TCyp; #) or CM SPRY
(”)( &). Nine hours after infection, cells were superinfected with HIV-1mt NL-DT5R. Culture supernatants were assayed
separately for levels of p24. Error bars show actual fluctuations between duplicate samples. Data from a representative of three
(a) or two (c) independent experiments are shown.
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http://vir.sgmjournals.org 599in Philippine CMs as a whole, but do not represent local
TRIMCyp distribution. In addition, hybridization with RMs
may affect the prevalence of TRIMCyp. As Chinese RMs
have been reported to have a low frequency of TRIMCyp
(Newmanet al., 2008; Wilson et al., 2008a),itis possible that
interspecies mating with Chinese RMs might result in a
lower prevalence of TRIMCyp in the Malaysian and
Indonesian populations. In any case, it will be of great
interest to determine the allele frequency of TRIMCyp in
wild CMs to confirm whether our results reflect the
observations in nature.
It is worth noting that the habitat of PMs is close to that of
CMs, and in fact both species inhabit Indonesia; however,
PMs reportedly express TRIMCyp but not TRIM5a
(Brennan et al., 2008; Liao et al., 2007). In contrast, the
allele frequency of TRIMCyp in Indonesian CMs was shown
to be markedly lower (Table 1). This discrepancy in
frequency of TRIMCyp between PMs and CMs suggests
that the two species have independently evolved antiretro-
viral factors to counteract some pathogen(s) existing in their
habitats. It is possible that unidentified co-factors that
interact with TRIM5a/TRIMCyp may have a role in this
discrepancy. Alternatively, the pathogen(s) could develop
severe diseases in either monkey species. In the case of RMs,
whilst the allele frequency of TRIMCyp was approximately
25% in the Indian population, TRIMCyp was not detected
in the Chinese population (Wilson et al., 2008a). Although
the precise reason(s) for these geographical deviations in
CMs and RMs is still unknown, it is reasonable to specu-
late that the possible pathogens, including exogenous and
endogenousretroviruses,are/wereheterogeneouslydissemin-
ated, depending on their habitats.
The amino acid sequence of the CypA domain of our CM
TRIMCyp-major (DK) is identicalto that of Mafa TRIMCyp2
cloned by Ylinen et al. (2010); thus, CM TRIMCyp-major
(DK) showed almost identical antiviral properties to those of
Mafa TRIMCyp2. However, CM TRIMCyp-major (DK)
slightly restricted HIV-2 GH123, although Mafa TRIMCyp2
failed to restrict HIV-2 ROD. This discrepancy is possibly due
to differences in assays; Ylinen and co-workers performed a
single-round infection assay using replication-incompetent
virus, whereas we performed a multiple-round replication
assay using replication-competent virus and thus our assay
could detect weak restriction activities. It is also possible
that differences in HIV-2 strains or TRIMCyp amino acid
differences outside the CypA domain could affect the result.
In the case of CM TRIMCyp-minor (NE), the amino acid
sequence of the CypA domain was identical to that of RM
TRIMCyp, and antiviral properties of CM TRIMCyp-minor
(NE) were the same as those of RM TRIMCyp. In addition,
exon 8 of both TRIMCyp genes showed a uniform sequence,
identical to that of the Mamu 7 haplotype of RMs. Exon 8 of
TRIMCyp would have been free from selection pressures, as
itis absentfrom themRNAdueto splicing,andthe ancestral
sequences in exon 8 would have been preserved. Taken
together, it is reasonable to speculate that this minor
haplotype of CM TRIMCyp was the ancestor when CMs
separated from RMs, and the major haplotype of CM
TRIMCyp has arisen due to a specific evolutionary pressure
on CMs. It should be noted that CM TRIM5a has Q at
aa 339, where RM TRIM5a has a QATFP polymorphism.
This QATFP polymorphism in the PRYSPRY domain also
altered the spectrum of anti-lentiviral activity of TRIM5a
(Kirmaier et al., 2010; Kono et al., 2008; Lim et al., 2010;
Wilson et al., 2008b). Therefore, it is tempting to speculate
that the selection pressure in CMs drove amplification
and diversification in TRIMCyp, whilst that in RMs drove
diversification of the PRYSPRY domain of TRIM5a.
In parallel with our study, Dietrich et al. (2011) recently
reported the prevalence and functionaldiversityofTRIMCyp
in CMs. They analysed populations from Indonesia,
Indochina, Mauritius and the Philippines, and found that
TRIMCyp was present in populations from Indonesia,
Indochina and the Philippines, but not in populations from
Mauritius. As they mentioned, the low genetic diversity,
probably due to founder effects, may have led to the absence
of TRIMCyp in the Mauritian population. In contrast, the
small number of animals analysed may have resulted in the
absence of TRIM5a in their Philippine population. They
also analysed the effects of DKANE substitution in CM
TRIMCyp on antiretroviral activity by mutagenesis tech-
niques.Furthermore,theyfoundauniqueindividualwiththe
DE haplotype in the CypA domain of TRIMCyp, whilst we
did not identify such a haplotype in our study. Their results
were essentially in accordance with ours, and we further
demonstrated that Philippine CMs possessed TRIM5a aswell
as TRIMCyp, suggesting that maintenance of both TRIM5a
and TRIMCyp in the CM population is beneficial to
counteract challenges by retroviruses that are susceptible to
TRIM5a and by those susceptible to TRIMCyp. Consistent
with this, Reynolds et al. (2011) demonstrated that hetero-
zygotes of RMs with TRIM5a and TRIMCyp showed higher
resistance to repeated intrarectal challenge of SIVsmE660
compared with homozygotes for TRIM5a or TRIMCyp.
Interestingly, this different outcome was not observed in the
case of intrarectal challenge with SIVmac239. As RM
TRIMCyp restricts SIVsm but not SIVmac (Kirmaier et al.,
2010), the combination of TRIM5a and TRIMCyp may
function more efficiently as an antiviral factor against SIVsm.
We saw a small difference in anti-HIV-1 activity between
CM TRIMCyp-minor (NE) and TRIMCyp-minor R285G.
Dietrich et al. (2011) suggested that either of two
polymorphic amino acid residues, K209E and R285G,
might be responsible for attenuated anti-feline immuno-
deficiency virus activity of a certain haplotype of CM
TRIMCyp. Our CM TRIMCyp-minor (NE) had K at aa
209, and an additional R285G mutation slightly attenuated
the anti-HIV-1 activity of CM TRIMCyp-minor (NE).
Residue 285 is in the linker region between the coiled-coil
and CypA domains. The precise mechanism of how aa 285
affects anti-HIV-1 activity is unclear at present, but our
result was consistent with those of Dietrich et al. (2011) and
further revealed the importance of a single amino acid
A. Saito and others
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TRIMCyp.
We showed that a prototypic HIV-1mt, named NL-DT5R,
encoding L4/5ofSIVmac239CAinsteadofthatderivedfrom
HIV-1, evaded restriction by the major haplotype of CM
TRIMCyp. As only HIV-1-derived L4/5 but not the SIVmac-
derived L4/5 is expected to bind to CypA (Franke et al.,
1994), the substitution of L4/5 results in loss of binding of
the capsid from CypA as well as TRIMCyp. Moreover, we
recently demonstrated that HIV-1mt has the ability to grow
in CMs (Saito et al., 2011). Retrospective analysis of the
TRIM5genotypesoftheinfectedCMsrevealedthattheywere
homozygous forTRIMCyp(data not shown),suggestingthat
TRIMCyp homozygotes allow the replication of HIV-1mt in
vivo. These findings will be helpful not only to understand
the molecular mechanisms of the species barrier of primates
to lentiviruses, but also to emphasize the importance of
TRIM5 genotypes for future studies regarding non-human
primate models for HIV-1 infection.
METHODS
Sample collection. Blood samples were obtained from CMs kept in
the Tsukuba Primate Research Center (TPRC), National Institute of
Biomedical Innovation, Tsukuba, Japan. CMs have been maintained
in indoor facilities as closed colony monkeys in TPRC since 1978
(Honjo, 1985). CMs in TPRC were obtained from Indonesia,
Malaysia and the Philippines. Although the detailed local information
of their origin is unclear, more than 100 animals were introduced to
each colony by dividing it several times. Basically, the monkeys have
been bred as pure blood of each origin without interbreed crossing.
The generation number of animals involved in this study ranged from
two to four when we consider the wild-caught founders (introduced
monkeys) as zero. These animals were maintained according to the
rules of the National Institute of Biomedical Innovation and
guidelines for experimental animal welfare. Bleeding was performed
under ketamine hydrochloride anaesthesia.
PCR amplification and sequence analysis. Genomic DNA was
extracted from peripheral blood mononuclear cells (PBMCs) of 126
CMs using a QIAamp DNA Blood Mini kit (Qiagen). To test for the
CypA insertion, the 39 region of the TRIM5 gene was amplified
by PCR using LA Taq (TaKaRa) with primers TC forward (59-
TGACTCTGTGCTCACCAAGCTCTTG-39) and TC reverse (59-
ACCCTACTATGCAATAAAACATTAG-39), as described by Wilson
et al. (2008a). The amplified products of CypA from 30 TRIMCyp
homozygotes and 32 TRIMCyp/TRIM5a heterozygotes were gel-
purified and subjected to direct sequencing using the forward and
reverse primers.
To determine the sequences of the RING, B-box, coiled-coil and
linker domains of TRIM5a and TRIMCyp, which span .15 kb of
genomic DNA, we prepared phytohaemagglutinin (PHA)-stimulated
PBMCs from six TRIMCyp homozygotes and three TRIM5a
homozygotes. Total RNA was extracted from these cells using
TRIzol (Invitrogen), and the RNA was reverse-transcribed using
SuperScript III reverse transcriptase (Invitrogen) with TC reverse
primer for TRIMCyp or TRIM5 reverse primer (59-GAATT-
CTCAAGAGCTTGGTGA-39) for TRIM5a. The resultant cDNA was
then PCR-amplified with LA Taq and forward primer TRIM5-235F
(59-GCAGGACCAGTGGAATAGC-39). The amplified products were
purified and subjected to direct sequencing using primers TRIM5-
235F, TRIM-N (59-AGGCAGAAGCAGCAGGAA-39), TRIM-Nrev
(59-TTCCTGCTGCTTCTGCCT-39) and TRIM-E (59-ACCTCCCAG-
TAATGTTTC-39). As the direct sequencing results of exons 5 and 6 of
TRIMCyp were ambiguous because of the existence of the other
splicing variant containing exons 1–4 combined with CypA (Brennan
et al., 2008), amplified products were then cloned into the vector
pCR-2.1TOPO (Invitrogen) and the nucleotide sequences of numer-
ous independent clones (between three and nine) for each TRIMCyp
were determined.
Exon 8 (PRYSPRY domain) was PCR-amplified from 12 TRIM5a
homozygotes and seven TRIMCyp homozygotes by using TRIM-
genotyping forward (59-CTTCTGAACAAGTTTCCTCCCAG-39) and
reverse (59-ATGAGATGCACATGGACAAGAGG-39) primers. The
amplified products were purified and subjected to direct sequencing
using the TRIM genotyping forward and reverse primers.
Cloning and expression of TRIMCyp. cDNA of the major
haplotype of CM TRIMCyp, CM TRIMCyp-major (DK), was
amplified by RT-PCR of mRNA extracted from the TRIM5a/
TRIMCyp-heterozygous CM T-cell line HSC-F using Not7TRIM5
(59-GCGGCCGCAGCTACTATGGCTTCTG-39) as the forward pri-
mer (NotI site underlined) and CypA Rev (59-ACGGCGGTCT-
TTTCATTCGAGTTGTCC-39) as the reverse primer. RM TRIMCyp
cDNA was amplified by RT-PCR of mRNA extracted from the
TRIMCyp homozygous RM T-cell line HSR5.4 using Not7TRIM5 as
the forward primer and CypA Rev as the reverse primer. The
amplified products were then cloned into pCR-2.1TOPO and the
authenticity of the nucleotide sequence was verified. To generate
TRIMCyp cDNAs carrying a haemagglutinin (HA; YPYDVPDYAA)
tag at the C terminus, the TRIMCyp cDNA clones were used as
templates for PCR amplification with a primer including a NotI site
and an HA tag.
To generate the minor haplotype, CM TRIMCyp-minor (NE), the C-
terminal portion of RM TRIMCyp (SalI–NotI) and the N-terminal
portion of CM TRIMCyp-major (DK) (NotI–SalI) were assembled in
the pcDNA3.1 (2) vector (Invitrogen). CM TRIMCyp-minor R285G
was generated by site-directed mutagenesis by a PCR-mediated
overlap primer-extension method.
The entire coding sequences of these TRIMCyps were then transferred
to the NotI site of the pSeV18+b( +) vector. Recombinant SeVs
carrying various TRIMCyp were recovered according to a previously
described method (Nakayama et al., 2005). The viruses were pas-
saged twice in embryonated chicken eggs and used as stocks for all
experiments.
Virus propagation. Virus stocks were prepared by transfection of
293T cells with HIV-1 NL4-3, HIV-2 GH123, SIVmac239 and HIV-
1mt NL-DT5R (Kamada et al., 2006) using a calcium phosphate co-
precipitation method. Virus titres were measured using p24 (for
HIV-1 and HIV-1mt) or p27 (for HIV-2 and SIVmac239) RetroTek
antigen ELISA kits (ZeptoMetrix).
Virus infection. Aliquots of 2610
5 MT4 cells were infected with SeV
expressing CM TRIM5a or each TRIMCyp at an m.o.i. of 10 and
incubated at 37 uC for 9 h. Cells were then superinfected with 20 ng
HIV-1 NL4-3 or HIV-1mt DT5R p24, 20 ng HIV-2 GH123 p25
or 20 ng SIVmac239 p27. The culture supernatants were collected
periodically, and the levels of p24, p25 and p27 were measured with a
RetroTek antigen ELISA kit.
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